Log In
Print
BCIQ
Print
Print this Print this
 

Aptivus, tipranavir

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionNon-peptidic protease inhibitor (PI)
Molecular Target HIV protease
Mechanism of ActionViral protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection in nonnucleoside reverse transcriptase inhibitor (NNRTI)-naïve patients who have failed 2 or more protease inbitor regimens; Treat HIV infection/AIDS; Treat HIV-1 infection in adults with evidence of viral replication and who are highly treatment experienced or who have multiple protease inhibitor resistance; Treat HIV-1 infection in combination with other antiretroviral agents in patients who are protease inhibitor experienced
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today